CN1739670A - Externally applied medicine of avicenna's pricklyash root - Google Patents
Externally applied medicine of avicenna's pricklyash root Download PDFInfo
- Publication number
- CN1739670A CN1739670A CN 200510098925 CN200510098925A CN1739670A CN 1739670 A CN1739670 A CN 1739670A CN 200510098925 CN200510098925 CN 200510098925 CN 200510098925 A CN200510098925 A CN 200510098925A CN 1739670 A CN1739670 A CN 1739670A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- external use
- radix zanthoxyli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention is one kind of externally applied medicine. The medicine is prepared with seven kinds of Chinese medicinal materials including avicenna's pricklyash root, madeiravine bulbil, radde anemone rhizome, coral ardisia root, common Indian mulberry root, etc. in certain proportion as well as alcohol solution in 75 % concentration. The synergistic effect of the Chinese medicinal materials makes the externally applied medicine possess high and determined effect and short treatment period on rheumatic arthralgia, traumatic injury, rheumatoid arthritis and other diseases.
Description
Technical field:
The present invention relates to a kind of Radix Zanthoxyli Avicennae medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of Radix Zanthoxyli Avicennae medicine for external use.
Choice of drug Radix Zanthoxyli Avicennae of the present invention, Bulbilus boussingaultiae pseudobaselloidis, Radde Anemone Rhizome, Radix Ardisiae Crenatae, Radix Morindae Umbellatae, Herba Aristolochiae Mollissimae, Caulis et Folium Elaeagni Henryi, ethanol (concentration is 75%) are formed; Wherein select Radix Zanthoxyli Avicennae for use: have expelling wind and removing dampness, the detumescence collateral dredging; Dispelling the wind and dampness pathogens arthralgia, traumatic injury stasis of blood pain, hypertrophiarthritis, traumatic injury.Bulbilus boussingaultiae pseudobaselloidis: have the detumescence dissipating blood stasis, relaxing muscles and tendons and activating QI and blood in the collateral; Control arthralgia, osteopatia sprain.Select Radde Anemone Rhizome for use: have expelling wind and removing dampness, reducing swelling and alleviating pain; Control arthralgia.Select Radix Ardisiae Crenatae for use: have eliminating stasis to stop pain; Control traumatic injury, rheumatalgia, Fengshi Guanjie is painful.Select Radix Morindae Umbellatae for use: have expelling wind and removing dampness; Control arthralgia, joint rheumatalgia.Select Herba Aristolochiae Mollissimae for use: have channels sootheing and network vessel quickening, promoting blood circulation and stopping pain; Dispelling the wind and dampness pathogens arthralgia.Select Caulis et Folium Elaeagni Henryi for use: have the fracture-setting powder stasis of blood, reducing swelling and alleviating pain.Dispelling the wind and dampness pathogens pain, treating swelling and pain by traumatic injury.Make the effect of each medicine produce collaborative effect these drug regimens, thereby the curative effect of disease that can realize effectively treating rheumatic arthritis, traumatic injury stasis of blood pain, hypertrophiarthritis, traumatic injury, arthralgia, bones and muscles pain, pain caused by ecchymoma, rheumatalgia, treating swelling and pain by traumatic injury, rheumatism, rheumatoid arthritis, wound stasis of blood pain, soft tissue contusion is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Radix Zanthoxyli Avicennae 1-16 part, Bulbilus boussingaultiae pseudobaselloidis 1-12 part, Radde Anemone Rhizome 1-8 part, Radix Ardisiae Crenatae 1-11 part, Radix Morindae Umbellatae 1-11 part, Herba Aristolochiae Mollissimae 1-8 part, Caulis et Folium Elaeagni Henryi 1-8 part, ethanol (concentration is 75%) 30-235 part.
Optimization formula of the present invention is:
14 parts of Radix Zanthoxyli Avicennaes, 11 parts of Bulbilus boussingaultiae pseudobaselloidiss, 6 parts of Radde Anemone Rhizomes, 9 parts of Radix Ardisiae Crenataes, 9 parts of Radix Morindae Umbellataes, 6 parts of Herba Aristolochiae Mollissimaes, 6 parts of Caulis et Folium Elaeagni Henryi, 200 parts of ethanol (concentration is 75%).
A kind of Radix Zanthoxyli Avicennae medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to the disease of treatment rheumatic arthritis, traumatic injury stasis of blood pain, hypertrophiarthritis, traumatic injury, arthralgia, bones and muscles pain, pain caused by ecchymoma, rheumatalgia, treating swelling and pain by traumatic injury, rheumatism, rheumatoid arthritis, wound stasis of blood pain, soft tissue contusion; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares a kind of Radix Zanthoxyli Avicennae medicine for external use of better efficacy with existing similar medicine for external use curative effect.Radix Zanthoxyli Avicennae medicine for external use of the present invention was once done a large amount of clinical trials in early stage, inferior between the 1999-2005 to over one hundred example on the patient treatment case, comprise the disease that is used for the treatment of rheumatic arthritis, traumatic injury stasis of blood pain, hypertrophiarthritis, traumatic injury, arthralgia, bones and muscles pain, pain caused by ecchymoma, rheumatalgia, treating swelling and pain by traumatic injury, rheumatism, rheumatoid arthritis, wound stasis of blood pain, soft tissue contusion, do not see untoward reaction during the treatment.Total effective rate is more than 83%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rubs affected part with the hands with the palm of the hand, and affected part is rubbed with the hands to generating heat for good every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix Zanthoxyli Avicennae medicine for external use provided by the present invention is made up of the component of following parts by weight; Radix Zanthoxyli Avicennae 1-16 part, Bulbilus boussingaultiae pseudobaselloidis 1-12 part, Radde Anemone Rhizome 1-8 part, Radix Ardisiae Crenatae 1-11 part, Radix Morindae Umbellatae 1-11 part, Herba Aristolochiae Mollissimae 1-8 part, Caulis et Folium Elaeagni Henryi 1-8 part, ethanol (concentration is 75%) 30-235 part.
Embodiment 2:
Optimization formula of the present invention is:
14 parts of Radix Zanthoxyli Avicennaes, 11 parts of Bulbilus boussingaultiae pseudobaselloidiss, 6 parts of Radde Anemone Rhizomes, 9 parts of Radix Ardisiae Crenataes, 9 parts of Radix Morindae Umbellataes, 6 parts of Herba Aristolochiae Mollissimaes, 6 parts of Caulis et Folium Elaeagni Henryi, 200 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Radix Zanthoxyli Avicennae, Bulbilus boussingaultiae pseudobaselloidis, Radde Anemone Rhizome, Radix Ardisiae Crenatae, Radix Morindae Umbellatae, Herba Aristolochiae Mollissimae, Caulis et Folium Elaeagni Henryi,, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of Radix Zanthoxyli Avicennae medicine for external use is characterized in that: Radix Zanthoxyli Avicennae, Bulbilus boussingaultiae pseudobaselloidis, Radde Anemone Rhizome, Radix Ardisiae Crenatae, Radix Morindae Umbellatae, Herba Aristolochiae Mollissimae, Caulis et Folium Elaeagni Henryi, ethanol (concentration is 75%) are formed.
2, a kind of Radix Zanthoxyli Avicennae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Radix Zanthoxyli Avicennae 1-16 part, Bulbilus boussingaultiae pseudobaselloidis 1-12 part, Radde Anemone Rhizome 1-8 part, Radix Ardisiae Crenatae 1-11 part, Radix Morindae Umbellatae 1-11 part, Herba Aristolochiae Mollissimae 1-8 part, Caulis et Folium Elaeagni Henryi 1-8 part, ethanol 30-235 part.
3, a kind of Radix Zanthoxyli Avicennae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 14 parts of Radix Zanthoxyli Avicennaes, 11 parts of Bulbilus boussingaultiae pseudobaselloidiss, 6 parts of Radde Anemone Rhizomes, 9 parts of Radix Ardisiae Crenataes, 9 parts of Radix Morindae Umbellataes, 6 parts of Herba Aristolochiae Mollissimaes, 6 parts of Caulis et Folium Elaeagni Henryi, 200 parts of ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100989255A CN100420462C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of avicenna's pricklyash root |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100989255A CN100420462C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of avicenna's pricklyash root |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739670A true CN1739670A (en) | 2006-03-01 |
| CN100420462C CN100420462C (en) | 2008-09-24 |
Family
ID=36092295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100989255A Expired - Fee Related CN100420462C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of avicenna's pricklyash root |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100420462C (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1104254C (en) * | 1999-12-25 | 2003-04-02 | 韦兴山 | Medicinal liquid for treating bone fracture |
-
2005
- 2005-09-11 CN CNB2005100989255A patent/CN100420462C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN100420462C (en) | 2008-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN100420462C (en) | Externally applied medicine of avicenna's pricklyash root | |
| CN100551415C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN100540020C (en) | A kind of Flos Carthami medicine for external use | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1739624A (en) | Externally applied medicine of aizoon stonecrop root | |
| CN100542549C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1739711A (en) | Externally applied medicine of rhodiola root | |
| CN1813992A (en) | Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls | |
| CN1739740A (en) | Externally applied medicine of fewleaf schnabelia herb | |
| CN1739708A (en) | Externally applied medicine of cannalike dona rhizome | |
| CN1739649A (en) | Externally applied wound treating medicine of miquel brookweed | |
| CN1739644A (en) | Externally applied medicine of fortune silene herb | |
| CN1739690A (en) | Externally applied medicine of Himalayan blueberry herb | |
| CN1751709A (en) | External use medicine for treating traumatic injury | |
| CN1739646A (en) | Externally applied medicine of thickleaf croton root | |
| CN1742856A (en) | Radix aconitic kusnezoffii external-use medicine | |
| CN1739636A (en) | Externally applied medicine of Chinese tinospora stem | |
| CN1751726A (en) | Fine spike acanthaceous external use medicine | |
| CN1814087A (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae | |
| CN1739701A (en) | Externally applied medicine of mantis for treating traumtic injury | |
| CN1813963A (en) | External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows | |
| CN1739630A (en) | Externally applied medicine of clarke boea herb |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080924 |